| Date Filed | Type | Description |
| 10/05/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,769 shares
@ $48.06, valued at
$181.1k
|
|
| 09/29/2023 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,600 shares
@ $48.84, valued at
$273.5k
Sold 12,102 shares
@ $49.93, valued at
$604.3k
Sold 400 shares
@ $50.5, valued at
$20.2k
Sold 6,898 shares
@ $50.17, valued at
$346.1k
Exercised 18,102 options to buy
@ $1.87, valued at
$33.9k
Exercised 6,898 options to buy
@ $1.87, valued at
$12.9k
|
|
| 08/25/2023 |
8-K
| Other Events Interactive Data |
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
8-K
| Other Events Interactive Data |
| 06/07/2023 |
4
| Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,307 shares
@ $52.06, valued at
$120.1k
|
|
| 06/07/2023 |
4
| Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,404 shares
@ $52.05, valued at
$73.1k
|
|
| 05/25/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/10/2023 |
ARS/A
| Form ARS/A - Annual Report to Security Holders: [Amend] |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/28/2023 |
8-K
| Quarterly results |
| 03/08/2023 |
4
| Murray Christopher K. (CHIEF TECHNICAL OPERATIONS) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,829 shares
@ $45.71, valued at
$83.6k
Sold 46 shares
@ $44.3, valued at
$2k
|
|
| 03/08/2023 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,960 shares
@ $45.72, valued at
$135.3k
Sold 99 shares
@ $44.28, valued at
$4.4k
|
|
| 03/08/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,885 shares
@ $45.72, valued at
$86.2k
Sold 63 shares
@ $44.36, valued at
$2.8k
|
|
| 03/08/2023 |
4
| Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,466 shares
@ $45.72, valued at
$67k
Sold 48 shares
@ $44.77, valued at
$2.1k
|
|
| 03/08/2023 |
4
| Lee Philina (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,622 shares
@ $45.72, valued at
$74.2k
Sold 54 shares
@ $44.4, valued at
$2.4k
|
|
| 03/08/2023 |
4
| Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,084 shares
@ $45.71, valued at
$141k
Sold 74 shares
@ $44.3, valued at
$3.3k
|
|
| 03/08/2023 |
4
| Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 736 shares
@ $45.72, valued at
$33.6k
Sold 25 shares
@ $44.78, valued at
$1.1k
|
|
| 03/08/2023 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 9,474 shares
@ $45.72, valued at
$433.2k
Sold 319 shares
@ $44.27, valued at
$14.1k
|
|
| 03/08/2023 |
4
| McCain Tracey L (EVP AND CHIEF LEGAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,216 shares
@ $45.72, valued at
$147k
Sold 106 shares
@ $44.41, valued at
$4.7k
|
|
| 03/08/2023 |
4
| Landsittel Michael (CFO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,911 shares
@ $45.72, valued at
$133.1k
Sold 96 shares
@ $44.48, valued at
$4.3k
|
|
| 03/08/2023 |
4
| Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,091 shares
@ $45.72, valued at
$49.9k
Sold 35 shares
@ $44.4, valued at
$1.6k
|
|
| 03/08/2023 |
4
| Haviland Kate (CEO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 6,428 shares
@ $45.72, valued at
$293.9k
Sold 212 shares
@ $44.65, valued at
$9.5k
|
|
| 03/03/2023 |
4
| Lee Philina (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Landsittel Michael (CFO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $43.15, valued at
$1.3M
|
|
|